- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05893992
fNIRS, Listening Effort, and Motivation
July 28, 2025 updated by: Sonova AG
Impacts of Hearing Aid Use on Listening Effort and Motivation Using fNIRS
The purpose of the current study is to measure oxygenation in the PFC using fNIRS in a sample of older adults with hearing loss.
Participants will be instructed to listen to sentences in noise at a challenging signal-to-noise-ratio, and to repeat the word that they heard and rate how much subjective listening effort was required in order to make out the words.
fNIRS will be measured throughout.
Participants will complete the task using a hearing aid program intended for listening in quiet, and a hearing aid program with new advanced noise management features.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
26
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Mississauga, Ontario, Canada, L5L1J3
- Sonova Innovation Centre Toronto
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Adults (18-99) years
- Binaural, symmetrical, sensorineural N2 (mild) to N5 (moderate-severe) hearing loss
- Fluent in English
Exclusion Criteria:
- Minors (17 years or less)
- Not able to tolerate wearing of hearing aids
- Vulnerable populations
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Digital noise management, then quiet listening
Participants with hearing loss who are candidates for hearing aids first listen using the device for hearing loss compensation with digital noise management features, followed by the device for hearing loss compensation for listening in quiet environments.
|
Device for hearing loss compensation with digital noise management features
Device for hearing loss compensation for listening in quiet environments
|
|
Experimental: Quiet listening, then digital noise management
Participants with hearing loss who are candidates for hearing aids first listen using the device for hearing loss compensation for listening in quiet environments, followed by the device for hearing loss compensation with digital noise management features.
|
Device for hearing loss compensation with digital noise management features
Device for hearing loss compensation for listening in quiet environments
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Oxygenation Using Functional Near Infrared Spectroscopy (fNIRS)
Time Frame: Session 1, 2, 3 and 4; assessed for up to 2 hours
|
Infrared light scattered from the prefrontal cortex, which is indicative of concentration of oxygenated blood in that region.
fNIRS in the prefrontal cortex is intended to index both motivation and listening effort.
|
Session 1, 2, 3 and 4; assessed for up to 2 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Listening Accuracy
Time Frame: Session 1, 2, 3 and 4; assessed for up to 2 hours
|
Speech understanding in noise percent correct scores
|
Session 1, 2, 3 and 4; assessed for up to 2 hours
|
|
Subjective Listening Effort Rating
Time Frame: Session 1, 2, 3 and 4; assessed for up to 2 hours
|
Participants rate how much listening effort was required in order to make out a sentence from 1-7, where lower scores mean less effort required.
|
Session 1, 2, 3 and 4; assessed for up to 2 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Jinyu Qian, PhD, Sonova AG
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 23, 2023
Primary Completion (Actual)
December 31, 2024
Study Completion (Actual)
December 31, 2024
Study Registration Dates
First Submitted
May 30, 2023
First Submitted That Met QC Criteria
May 30, 2023
First Posted (Actual)
June 8, 2023
Study Record Updates
Last Update Posted (Actual)
August 17, 2025
Last Update Submitted That Met QC Criteria
July 28, 2025
Last Verified
May 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SRF-15557
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
There is no plan to share individual participant data with other researchers.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hearing Loss
-
MED-EL Elektromedizinische Geräte GesmbHCompletedHearing Loss | Hearing Loss, Sensorineural | Hearing Loss, Bilateral | Hearing Loss, Conductive | Hearing Loss, Unilateral | Hearing Loss, MixedAustria, Germany, United Kingdom
-
Oticon MedicalCompletedEar Diseases | Hearing Loss, Conductive | Hearing Loss Mixed | Hearing Disability | Conductive Hearing Loss | Conductive Hearing Loss, Bilateral | Conductive Hearing Loss, UnilateralUnited Kingdom
-
Oticon MedicalNot yet recruitingSensorineural Hearing Loss, Bilateral | Sensorineural Hearing Loss, Severe | Sensorineural Hearing Loss, Profound
-
University of California, San FranciscoPatient-Centered Outcomes Research InstituteRecruitingHearing Loss | Hearing Loss, Sensorineural | Hearing Loss, Bilateral | Hearing Loss, Conductive | Hearing Loss, Noise-Induced | Hearing Loss, Unilateral | Hearing Loss, Mixed | Hearing Disorders in ChildrenUnited States
-
Manchester University NHS Foundation TrustUniversity of ManchesterCompletedCochlear Hearing Loss | Sensorineural Hearing Loss, BilateralUnited Kingdom
-
Truway Health, Inc.Enrolling by invitationSensorineural Hearing Loss | Tinnitus | Sudden Hearing Loss | Acoustic Trauma | Inner Ear Injury | Noise-Induced Hearing Loss | Vestibular DysfunctionUnited States
-
Envoy Medical CorporationActive, not recruitingSensorineural Hearing Loss | Sensorineural Hearing Loss (Disorder) | Sensorineural Hearing Loss, Bilateral | Sensorineural Hearing Loss, Severe | Sensorineural Hearing Loss, Profound | Sensori-Neural DeafnessUnited States
-
Oticon MedicalCompletedConductive Hearing Loss | Conductive and Sensori-neural Hearing Loss in the Same Ear | Unilateral, Profound Sensori-neural Hearing LossUnited States
-
Frequency TherapeuticsCompletedHearing Loss, Sensorineural | Presbycusis | Noise Induced Hearing Loss | Sudden Hearing LossUnited States
-
Frequency TherapeuticsCompletedHearing Loss, Sensorineural | Noise Induced Hearing Loss | Sudden Hearing LossUnited States
Clinical Trials on Hearing aids with noise management features for listening in noise
-
Sonova AGCompleted
-
Akdeniz UniversityCompletedSurgical Procedures, Elective | Nurse Based Care ManagementTurkey (Türkiye)